PHASE III

Clinical trials for PHASE III explained in plain language.

Never miss a new study

Get alerted when new PHASE III trials appear

Sign up with your email to follow new studies for PHASE III, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 1

New drug shows promise for back pain from ankylosing spondylitis

Disease control Completed

This study tested a new antibody drug (XKH004) in 323 adults with moderate-to-severe active ankylosing spondylitis, a type of arthritis that causes back pain and stiffness. The drug aims to reduce inflammation by blocking certain proteins. Participants received either the drug or…

Matched conditions: PHASE III

Phase: PHASE3 • Sponsor: Zhejiang Kanova Biopharmaceutical Co., LTD • Aim: Disease control

Last updated May 03, 2026 22:02 UTC

PHASE III

Get alerted when new PHASE III trials appear

New drug shows promise for back pain from ankylosing spondylitis